Lunai Bioworks (LNAI) Non-Current Debt (2012 - 2022)
Lunai Bioworks (LNAI) recorded quarterly Non-Current Debt of $4.7 million in Q3 2022, up 1.63% quarter-over-quarter from $4.6 million in Q2 2022, and little changed on a YoY basis from $4.7 million in Q3 2021.
Lunai Bioworks (LNAI) Non-Current Debt (2012 - 2022) Analysis & Trends
Lunai Bioworks' Non-Current Debt history runs 4 years deep, the most recent figure standing at $4.7 million for Q3 2022.
- In Q3 2022, Non-Current Debt changed 0.03% year-over-year to $4.7 million; the TTM figure through Sep 2022 stood at $4.7 million (changed 0.03% YoY), while the FY2022 annual figure was $4.6 million, changed 0.04% from the prior year.
- Non-Current Debt was $4.7 million for Q3 2022 at Lunai Bioworks, up from $4.6 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $4.7 million in Q4 2020 to a low of $4.5 million in Q1 2021.
- Historically, Non-Current Debt has averaged $4.6 million across 3 years, with a median of $4.6 million in 2020.
- Biggest YoY gain for Non-Current Debt was 0.03% in 2021; the steepest drop was 0.04% in 2021.
- A 3-year view of Non-Current Debt shows it stood at $4.7 million in 2020, then declined by 1.59% to $4.7 million in 2021, then slipped by 0.03% to $4.7 million in 2022.
- The last three Non-Current Debt figures came in at $4.7 million (Q3 2022), $4.6 million (Q2 2022), and $4.7 million (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 4.65 Mn |
| Sep 30, 2022 | 4.65 Mn |
| Jun 30, 2022 | 4.58 Mn |
| Jun 30, 2022 | 4.58 Mn |
| Sep 30, 2021 | 4.65 Mn |
| Sep 30, 2021 | 4.65 Mn |
| Jun 30, 2021 | 4.58 Mn |
| Jun 30, 2021 | 4.58 Mn |
| Mar 31, 2021 | 4.50 Mn |
| Mar 31, 2021 | 4.50 Mn |
| Dec 31, 2020 | 4.73 Mn |
| Dec 31, 2020 | 4.73 Mn |
| Sep 30, 2020 | 4.65 Mn |
| Sep 30, 2020 | 4.65 Mn |
| Jun 30, 2020 | 4.58 Mn |
| Jun 30, 2020 | 4.58 Mn |
| Mar 31, 2020 | 4.51 Mn |
| Mar 31, 2020 | 4.51 Mn |
| Dec 31, 2012 | 795,785.00 |
| Dec 31, 2012 | 795,785.00 |